Your search for major depressive disorder returned 133 results

For Chinese adults with normal kidney function, higher depressive symptoms are associated with an increased risk for rapid kidney function decline.

This genome-wide associated study expanded on the gene-environment correlation for childhood maltreatment and causal relationship between childhood maltreatment and health.

People with epilepsy are more likely to experience psychiatric comorbidities, which can have a highly negative effect on their condition, their mental state, and their overall quality of life. What are some of the effects stress and depression can have on a patient’s epilepsy?

In order to assess asymptomatic infections and immunologic responses to COVID-19, a team of researchers tested for SARS-CoV-2 antibodies in a multiple sclerosis cohort.

Psilocybin has been shown to have antidepressant properties. With direct comparisons between psilocybin and established treatments for depression lacking, the study researchers looked at psilocybin and escitalopram.

AXS-05 consists of dextromethorphan, an NMDA receptor antagonist, and bupropion, a norepinephrine and dopamine reuptake inhibitor.

Researchers compared how patients experiencing a major depressive episode and control participants perceived contrast patterns.

For patients with MDD, the change in scores for depression at six weeks does not differ significantly with psilocybin or psilocybin plus escitalopram.

To evaluate whether patients with isolated dystonia are at an increased risk for suicidal behavior, researchers administered an anonymous electronic survey.

The researchers sought to estimate the age-specific incidence and prevalence of dementia diagnoses among older adults with schizophrenia in the United States compared to those without serious mental illness.

The percentage of adults with mental health issues increased, as did the percentage reporting that they needed but did not receive help.

For people with dementia with symptoms of depression, without a MDD, nondrug interventions are more efficacious than drug interventions.

Solriamfetol, a dopamine-norepinephrine reuptake inhibitor, improves excessive daytime sleepiness in OSA regardless of primary OSA therapy adherence.

A team of researchers sought to investigate the bidirectional relationship between multiple sclerosis and major depressive disorder with Mendelian randomization.

More than half of individuals with prior COVID-19 illness have met the criteria for symptoms of major depressive disorder.

Researchers from Dalhousie University in Canada searched publication databases through September of 2020 for articles on ADHD, attention deficit disorder, bipolar disorder, and affective psychosis.

Researchers set out to evaluate whether propranolol efficacy is greater in people with comorbid migraine compared with those without migraine.

Study investigators sought to determine if galcanezumab would reduce not only the frequency of migraine days but also the disabling nonpain symptoms of episodic and chronic migraine.

The goals of this study were to identify functional connectome fingerprints that predict symptom improvement with any treatment and with specific treatment.

A team of researchers sought to evaluate the potential of virtual reality technologies for rehabilitation of patients with Duchenne muscular dystrophy.

This study explores the issue of suicidality in children and youth with epilepsy and psychiatric comorbidities.

The researchers analyzed data from a large randomized noninferiority trial that compared theta-burst stimulation and high-frequency (10 Hz) rTMS delivered to the left dorsolateral prefrontal cortex.

The objective of this post hoc analysis is to better assess the benefits of fremanezumab in patients who responded to treatment during 2 phase 3 HALO clinical trials.

Recently updated diagnostic criteria for fibromyalgia that reduce the underdiagnosis in men had not been implemented during these studies.

With little being known about the predictors or moderators of dTMS outcome for OCD, this study sought to examine if several theoretically relevant variables may predict and moderate treatment effects including OCD symptom severity, functional impairment, co-occurring depressive symptoms, age, gender, age of OCD onset, and family history of OCD.

This study addresses the question of whether prescription opioid medications has a potentially causal role in the risk for depression and anxiety disorder.

Longitudinal changes in the dopamine transporter availability may identify patients with idiopathic REM sleep behavior disorder who are at risk of conversion to neurodegenerative diseases.

Edoxaban was found to be superior to placebo for the prevention of stroke and systemic embolism in very elderly Japanese patients with nonvalvular atrial fibrillation.

Researchers looked to further connect the dots between cognitive behavioral therapy for insomnia and repetitive negative thinking.

Can pain intensity scores predict psychosocial outcomes longitudinally? This study examines that question.